Hormone Therapy After Age 65 Linked to Increased Cancer and Stroke Risk
A study of over 83,000 women found that initiating hormone therapy after age 65 significantly increases risks for cancer and cerebrovascular events, reinforcing current guidelines that discourage starting systemic hormone therapy after age 60.